Search

Search Constraints

You searched for: Author/Creator Chang, Jenny

Search Results

3. 712 SBT6290, a systemically administered Nectin-4-directed TLR8 ImmunoTAC (TM) therapeutic, is a potent human myeloid cell agonist for the treatment of Nectin-4-expressing tumors. (9th November 2020)

4. 712 SBT6290, a systemically administered Nectin-4-directed TLR8 ImmunoTAC (TM) therapeutic, is a potent human myeloid cell agonist for the treatment of Nectin-4-expressing tumors. (9th November 2020)

5. Adherence to ophthalmology referral, treatment and follow-up after diabetic retinopathy screening in the primary care setting. Issue 1 (23rd June 2020)

6. Adherence to ophthalmology referral, treatment and follow-up after diabetic retinopathy screening in the primary care setting. Issue 1 (23rd June 2020)

7. Adherence to ophthalmology referral, treatment and follow-up after diabetic retinopathy screening in the primary care setting. Issue 1 (23rd June 2020)

8. Adherence to ophthalmology referral, treatment and follow-up after diabetic retinopathy screening in the primary care setting. Issue 1 (23rd June 2020)

9. Adherence to ophthalmology referral, treatment and follow-up after diabetic retinopathy screening in the primary care setting. Issue 1 (23rd June 2020)

10. Adherence to ophthalmology referral, treatment and follow-up after diabetic retinopathy screening in the primary care setting. Issue 1 (23rd June 2020)